Search for: "Price v. Cohen" Results 41 - 60 of 189
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2016, 3:23 am
London housing prices would suggest otherwise, but the rejection of capitalism in favour of open-source, commons approaches sparks some interesting debates, says Nicola. * Are myth and metaphor the primary drivers of innovation in intellectual property law? [read post]
21 Aug 2009, 12:08 am
The South Florida lawyers blog writes about their blow up and here is a copy of the shocking complaint in Leighton v. [read post]
18 May 2014, 11:07 am by Brian E. Barreira
The position of the Office of Medicaid is directly contrary to what the Supreme Judicial Court wrote in Cohen v. [read post]
18 May 2014, 11:07 am by Brian E. Barreira
The position of the Office of Medicaid is directly contrary to what the Supreme Judicial Court wrote in Cohen v. [read post]
4 Jul 2012, 12:42 am by Mark Tushnet
Tom Krattenmaker recently published a terrific inside account of Cohen v. [read post]
3 Dec 2013, 6:13 am by Amy Howe
Briefly: In The Atlantic, Andrew Cohen urges the Court to grant review in Gomez v. [read post]
9 Dec 2013, 12:28 am by Peter Mahler
Here’s what he says: The Limited Liability Company Law does not expressly authorize a buyout in a dissolution proceeding (Mizrahi v Cohen, 104 AD3d 917, 920 [2d Dept 2013]). [read post]
22 Jun 2011, 6:39 am by Adam Chandler
The Atlantic’s Andrew Cohen deems Turner – which he describes as “Gideon v. [read post]
6 Apr 2015, 7:31 am
 * BREAKING: Copyright, links to leaks, celebrity pics and free speech as CJEU to get a dekko at DekkerKatfriend Tobias Cohen Jehoram (De Brauw Blackstone Westbroek NV, Amsterdam) recounts a Dutch tale of links to unpublished pictures of a local celebrity named Britt Dekker before their launch on Playboy.* Have a niche time! [read post]
15 Mar 2019, 9:00 am by Staff
Subsequent to the FDA approval of Epidiolox, The Drug Enforcement Administration (DEA) issued a Final Order placing “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols” [such as Epidiolox] in Schedule V of the Controlled Substances Act,”  “Schedule V drugs are considered to have the lowest potential for abuse compared to other scheduled drugs and a low potential for psychological or physical… [read post]